Discovery of a novel glial autoantibody specific for myelin oligodendrocyte glycoprotein (MOG) has enabled recognition of antigen-specific inflammatory demyelinating diseases of the central nervous system (CNS) manifesting as optic neuritis [1,2,3]. This evidence concerns the gene MOG and optic neuritis.